{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:14:46Z","timestamp":1773292486475,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.amjmed.2012.06.027","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T02:05:50Z","timestamp":1358301950000},"page":"133-140.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["CHADS  Score, Statin Therapy, and Risks of Atrial Fibrillation"],"prefix":"10.1016","volume":"126","author":[{"given":"Chen-Ying","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Heng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El-Wui","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Tai","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsu-Juey","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2012.06.027_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.158.3.229","article-title":"Impact of atrial fibrillation on mortality, stroke, and medical costs","volume":"158","author":"Wolf","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2012.06.027_bib2","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.jacc.2009.08.020","article-title":"Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)","volume":"54","author":"Haywood","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjmed.2012.06.027_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/europace\/eur016","article-title":"The incidence and risk factors for new onset atrial fibrillation in the PROSPER study","volume":"13","author":"Macfarlane","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2012.06.027_bib4","doi-asserted-by":"crossref","first-page":"2N","DOI":"10.1016\/S0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2012.06.027_bib5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0002-9343(99)80348-9","article-title":"The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study","volume":"98","author":"Krahn","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.amjmed.2012.06.027_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eur002","article-title":"Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines","volume":"13","author":"Savelieva","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2012.06.027_bib7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2012.06.027_bib8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.hrthm.2011.03.016","article-title":"Associations among the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation","volume":"8","author":"Chao","year":"2011","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.amjmed.2012.06.027_bib9","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/europace\/eur135","article-title":"The electroanatomical remodelling of the left atrium is related to CHADS2\/CHA2DS2VASc score and events of stroke in patients with atrial fibrillation","volume":"13","author":"Park","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.amjmed.2012.06.027_bib10","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.amjmed.2012.06.027_bib11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1586\/erc.10.79","article-title":"Cholesterol and cardiac arrhythmias","volume":"8","author":"Goonasekara","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjmed.2012.06.027_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1540-8159.2010.02942.x","article-title":"Upstream effect for atrial fibrillation: still a dilemma?","volume":"34","author":"Calo","year":"2011","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.amjmed.2012.06.027_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/eurheartj\/ehr460","article-title":"High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial","volume":"33","author":"Pena","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2012.06.027_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/clinchem\/47.3.403","article-title":"High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease","volume":"47","author":"Rifai","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.amjmed.2012.06.027_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2010.03.067","article-title":"Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation","volume":"106","author":"Maehama","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjmed.2012.06.027_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1540-8159.2009.02339.x","article-title":"Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently","volume":"32","author":"Crandall","year":"2009","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312005955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934312005955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:59:51Z","timestamp":1757581191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934312005955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0002934312005955"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.06.027","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHADS2 Score, Statin Therapy, and Risks of Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2012.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}